APLN and chronic kidney disease: In CKD, and compared to placebo, [Pyr1]apelin-13 1 nmol/min increased urinary sodium excretion by ~ 40 μmol/min (p < 0.0001), with a similar response seen at [Pyr1]apelin-13 30 nmol/min.